Metformin Inhibits Hepatic Gluconeogenesis Through AMP-Activated Protein Kinase–Dependent Regulation of the Orphan Nuclear Receptor SHP
Online-Only Appendix
Files in this Data Supplement:
- Supplemental FIG. 1. AMPK activation induces AMPK phosphorylation and represses hepatic gluconeogenic gene expression via SHP.
- Supplemental FIG. 2. Metformin inhibits the promoter activities and gene expression of hepatic gluconeogenic genes.
- Supplemental FIG. 3. Downregulations of PEPCK and G6Pase gene expression by metformin are mediated via SHP.
- Supplemental FIG. 4. Metformin increases the phosphorylation of ACC and AMPK in liver of B6-Lepob/ob mice in a dose-dependent manner.
- Supplemental Figure Legends
This Article
-
Diabetes February 2008 vol. 57 no. 2 306-314
- Abstract
- Full Text
- Full Text (PDF)
- » Online-Only Appendix
Current Issue
Issue Highlights
- Anatomical Locations of Human Brown Adipose Tissue: Functional Relevance and Implications in Obesity and Type 2 Diabetes
- Biochemical Basis of the Antidiabetic Activity of Oleanolic Acid and Related Pentacyclic Triterpenes
- SIRT1, p66Shc, and Set7/9 in Vascular Hyperglycemic Memory: Bringing All the Strands Together
- Using the Past to Inform the Future: Anti-VEGF Therapy as a Road Map to Develop Novel Therapies for Diabetic Retinopathy
- sRAGE and Risk of Diabetes, Cardiovascular Disease, and Death
